Patient Participation Vital To Research

Share Article

Kidney Cancer Association educates patients about the value of clinical trials.

we’re trying to spread the word about the value of clinical trials

“March is Kidney Cancer Awareness month and the Kidney Cancer Association (KCA) wants to help patients to better understand the vital role they can play in advancing research,” says Bill Bro, CEO of the world’s largest voluntary health organization that serves families dealing with kidney cancer. Bro is a 26 year survivor of the disease.

The Chicago based charity has launched a campaign to educate families about how participating in a clinical trial helps to speed new cancer treatments from the laboratory to the bedside. “Patients should frequently check the Pressroom section of our home page at to stay abreast of current research,” Bro adds.

“We've seen an unprecedented rollout of new therapies for the treatment of advanced kidney cancer over the past seven years,” Bro says. “None of this would have happened without the voluntary participation of thousands of patients in clinical trials. But, with these advancements, it has become more difficult to find previously untreated people with advanced disease who are willing to participate in clinical research. This slows progress, so we’re trying to spread the word about the value of clinical trials.”

Each month, the Kidney Cancer Association plans to feature information about clinical trials on its website’s home page, as well as through various social media. KCA’s Facebook page may be found at

The Kidney Cancer Association is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest organization of its kind, with members in more than 100 countries. It funds, promotes, and collaborates with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA), and other institutions on research projects. It educates families and physicians, and serves as an advocate on behalf of patients at the state and federal levels in the United States and globally.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carrie Konosky
Visit website